This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Lactate Dehydrogenase A (LDHA) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine lactate dehydrogenase A. It can be applied to WB; IHC and IP assays of canine lactate dehydrogenase A.
Specifications
Target Information
Canine lactate dehydrogenase A (LDHA) is a key enzyme involved in the conversion of pyruvate to lactate during anaerobic glycolysis, playing a crucial role in energy metabolism, especially under hypoxic conditions. This enzyme facilitates the Warburg effect, where cancer cells preferentially utilize glycolysis for energy production, even in the presence of oxygen. Elevated levels of LDHA have been linked to tumor growth, maintenance, and invasion, making it a promising target for cancer diagnosis and therapy. In dogs, understanding LDHA's function can provide insights into metabolic disorders and the development of therapeutic strategies for conditions such as cancer, where LDHA inhibition may restrict tumor energy supply and reduce malignancy.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.